Evidence map›Paper›PMID 32640908›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2020

Fibulin-1 Integrates Subendothelial Extracellular Matrices and Contributes to Anatomical Closure of the Ductus Arteriosus.

Satoko Ito, Utako Yokoyama, Taichi Nakakoji, Marion A Cooley, Takako Sasaki, Sonoko Hatano, Yuko Kato, Junichi Saito, Naoki Nicho, Shiho Iwasaki and 5 more

Open access · hybridAbstract readVideo-Audio Media
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The molecular mechanisms of cardiac development and related diseases.Signal transduction and targeted therapy · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. V3: an enigmatic isoform of the proteoglycan versican.American journal of physiology. Cell physiology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Mouse models of patent ductus arteriosus (PDA) and their relevance for human PDA.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Satoko ItoFrom the Cardiovascular Research Institute (S.I., U.Y., T.N., J.S., N.N., M.U., T.F., Y.I.), Yokohama City University, Japan.
Utako YokoyamaFrom the Cardiovascular Research Institute (S.I., U.Y., T.N., J.S., N.N., M.U., T.F., Y.I.), Yokohama City University, Japan.
Taichi NakakojiFrom the Cardiovascular Research Institute (S.I., U.Y., T.N., J.S., N.N., M.U., T.F., Y.I.), Yokohama City University, Japan.
Marion A CooleyDepartment of Oral Biology and Diagnostic Sciences, Augusta University, GA (M.A.C.).
Takako SasakiDepartment of Biochemistry II, Oita University, Japan (T.S.).
Sonoko HatanoInstitute for Molecular Science of Medicine, Aichi Medical University, Japan (S.H.).
Yuko KatoDepartment of Physiology, Tokyo Medical University, Japan (S.I., U.Y., Y.K., J.S.).
Junichi SaitoFrom the Cardiovascular Research Institute (S.I., U.Y., T.N., J.S., N.N., M.U., T.F., Y.I.), Yokohama City University, Japan.
Naoki NichoFrom the Cardiovascular Research Institute (S.I., U.Y., T.N., J.S., N.N., M.U., T.F., Y.I.), Yokohama City University, Japan.
Shiho IwasakiDepartment of Pediatrics (S.I.), Yokohama City University, Japan.
Masanari UmemuraFrom the Cardiovascular Research Institute (S.I., U.Y., T.N., J.S., N.N., M.U., T.F., Y.I.), Yokohama City University, Japan.
Takayuki FujitaFrom the Cardiovascular Research Institute (S.I., U.Y., T.N., J.S., N.N., M.U., T.F., Y.I.), Yokohama City University, Japan.
Munetaka MasudaDepartment of Surgery (M.M.), Yokohama City University, Japan.
Toshihide AsouDepartment of Cardiovascular Surgery, Kanagawa Children's Medical Center, Yokohama, Japan (T.A.).
Yoshihiro IshikawaFrom the Cardiovascular Research Institute (S.I., U.Y., T.N., J.S., N.N., M.U., T.F., Y.I.), Yokohama City University, Japan.
Yokohama City University · JPTokyo Medical University · JPAichi Medical University · JPAugusta University · USKanagawa Children's Medical Center · JPOita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe ductus arteriosus (DA) is a fetal artery connecting the aorta and pulmonary arteries. Progressive matrix remodeling, that is, intimal thickening (IT), occurs in the subendothelial region of DA to bring anatomic DA closure. IT is comprised of multiple ECMs (extracellular matrices) and migrated smooth muscle cells (SMCs). Because glycoprotein fibulin-1 binds to multiple ECMs and regulates morphogenesis during development, we investigated the role of fibulin-1 in DA closure. Approach and Results: Fibulin-1-deficient (

conclusionsFibulin-1 contributes to DA closure by forming an environment favoring directional SMC migration toward the subendothelial region, at least, in part, in combination with EC-derived versican and its binding partner hyaluronan.

Indexed as

AnimalsCalcium-Binding ProteinsCell MovementCells, CulturedCoculture TechniquesDuctus ArteriosusDuctus Arteriosus, PatentEndothelial CellsExtracellular MatrixHumansMice, 129 StrainMice, Inbred C57BLMice, KnockoutMyocytes, Smooth MuscleNF-kappa BOrgan Culture TechniquesCalcium-Binding ProteinsfibulinNF-kappa BProtein Kinase CPtger4 protein, mouseReceptors, Prostaglandin E, EP4 SubtypeType C Phospholipasesductus arteriosusextracellular matrixfibulinmiceneointimavascular remodelingversicans

Identifiers

PMID32640908
PMCPMC7447190
OpenAlexW3041366450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.